Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)

Market Cap	17.03B
Revenue (ttm)	4.14B
Net Income (ttm)	422.40M
Shares Out	832.47M
EPS (ttm)	0.50
PE Ratio	40.84
Forward PE	34.10
Dividend	0.22 (1.06%)
Ex-Dividend Date	Jul 14, 2025

Volume	5,909,753
Average Volume	6,686,656
Open	20.45
Previous Close	20.84
Day's Range	20.44 - 20.89
52-Week Range	15.90 - 29.40
Beta	0.62
RSI	59.64
Earnings Date	Aug 25, 2025

About Huaxia Eye Hospital Group

Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis and treatment services for patients with ophthalmic diseases; and myopia prevention and intervention work to the public. It offers services in the areas of cataract, refraction, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular surface, glaucoma, orbital and ocular tumors, and ocular trauma. The company was founded in 2004 and is based in Xiamen, China.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2004
• Employees: 7,883
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301267

Financial Performance

In 2024, Huaxia Eye Hospital Group's revenue was 4.03 billion, an increase of 0.35% compared to the previous year's 4.01 billion. Earnings were 428.64 million, a decrease of -35.63%.